Kuehn Law investigates potential fiduciary breaches at TG Therapeutics

Sep 28, 2026 09:26 (25d ago)

Kuehn Law is investigating potential fiduciary breaches involving TG Therapeutics officers and directors.
The probe concerns possible self-dealing by certain company officers and directors.
The investigation could result in shareholder damages and corporate governance reforms.

Kuehn Law, PLLC is investigating whether certain officers and directors of TG Therapeutics, Inc. breached their fiduciary duties through potential self-dealing. The legal probe could lead to damages for shareholders and reforms in corporate governance.